Pilot Study to Assess the Effects of AV608 on Irritable Bowel Syndrome: "The purpose of this study is to assess the effects of AV608, a neurokinin 1 (NK-1) antagonist, in subjects with Irritable Bowel Syndrome. "
Saturday, April 29, 2006
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment